Dalton Chemical Laboratories, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, has completed Phase III of its facilities expansion
Bringing its total investment in the Wildcat site to over C$7 million, the $1.4 million expansion includes a peptide production laboratory, a microbiology laboratory, a QA Sampling suite, an oligonucleotide production suite, a back up generator and a UPS system.
"We are pleased to continue to add to our world class research and manufacturing facilities for our Canadian and worldwide customer base.
"Pharmaceutical development is a tremendous area to be in right now as many exciting new approaches to treat disease are coming to fruition.
"By providing medicinal chemistry, integrated GMP synthesis and sterile fill in the same facility, Dalton can now reduce the development time for our clients dramatically," states Peter Pekos, president and CEO.
The peptide laboratory accommodates a variety of peptide synthesis, purification and analysis equipment from micro scale to hundred gram production scale.
The space is equipped with two walk-in fume hoods, a bench top fume hood and a separate, negatively pressured solvent removal room. Dalton's in house microbial monitoring capabilities have been expanded with the new microbiology laboratory.
It is outfitted for biohazard safety level 2 conditions with a variety of incubators and biohazard hoods to ensure safe handling and processing.
An oligonucleotide production suite is equipped with the latest technology that allows small to large scale oligo production and purification capabilities.
Equipment includes 4 Akta OligoPilots each capable of producing 50g of oligo per run. Dalton says the addition of a state of the art regulated QA sampling suite equipped with the latest monitoring and safety devices is a key step in its GMP compliance.
A back up generator that can support a facility twice Dalton's current size was installed to ensure that the production will continue during any main grid malfunctions.
Installation of a new uninterruptible power supply ensures that all critical GMP and analytical equipment at Dalton is protected from any power fluctuation.
